New treatment approach for mantle cell lymphoma
Developing novel therapy to improve outcomes in MCL
This study is looking at a new treatment for mantle cell lymphoma (MCL) that targets a specific protein to help kill cancer cells and hopefully improve outcomes for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10886820 on NIH RePORTER |
What this research studies
This research focuses on developing a novel therapy for mantle cell lymphoma (MCL), a type of non-Hodgkin lymphoma that is currently incurable. The study investigates the role of Fibroblast Growth Factor Receptor-1 (FGFR1) in MCL survival and how it regulates cell cycle processes. By targeting FGFR1 with a specific drug, the research aims to induce cell death in cancer cells and improve patient outcomes. Patients may benefit from preclinical studies that explore the effectiveness of this targeted therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with mantle cell lymphoma who have experienced relapse after standard treatments.
Not a fit: Patients with other types of lymphoma or those who have not been diagnosed with mantle cell lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better treatment options for patients with relapsed mantle cell lymphoma.
How similar studies have performed: Previous research has shown promising results in targeting FGFR1 in other cancers, suggesting potential success for this novel approach in mantle cell lymphoma.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Sehgal, Lalit — Ohio State University
- Study coordinator: Sehgal, Lalit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.